Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...

2025 $10.1 million in net sales from migraine products in 2024 CHATHAM, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a ...

When it comes to movies, we often don’t think too much about the posters. But believe it or not, some of these art pieces ...

Sykes appeared on Thin Lizzy's harder-edged 1983 album Thunder and Lightning, the group's Top 5 U.K. hit studio finale with ...

A new international poster for Disney's live-action Snow White movie has been shared online, giving us another look at Rachel ...

Several new Born Again promo stills from the latest issue of Empire Magazine have been shared online, and we also have a ...

UFC 313 poster for the Alex Pereira vs. Magomed Ankalaev pay-per-view (PPV) event, recently announced for Sat., March 8, 2025 ...

AVEO Oncology, an LG Chem company ("AVEO"), is a biopharmaceutical company that is trying to provide differentiated solutions ...

Ankalaev is unbeaten in his past 12 fights as he gets his second opportunity at UFC championship gold. In his first title ...

UMass said it would pay a student the $10,000 prize for a halftime promotion at a women’s basketball game after a dispute with an insurance company over whether he stepped over the line when he ...

Figure 1: Antibody design to improve homogeneity and potential for development. Antibodies are a successful class of therapeutic agents, but many treaments remain costly, which may limit their use ...